1. Home
  2. CANG vs TNXP Comparison

CANG vs TNXP Comparison

Compare CANG & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cango Inc.  each representing two (2)

CANG

Cango Inc. each representing two (2)

HOLD

Current Price

$0.41

Market Cap

185.4M

Sector

Technology

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$12.40

Market Cap

198.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CANG
TNXP
Founded
2010
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.4M
198.6M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
CANG
TNXP
Price
$0.41
$12.40
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
1.4M
382.0K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.75
EPS
N/A
N/A
Revenue
N/A
$13,107,000.00
Revenue This Year
$428.72
$558.11
Revenue Next Year
$18.39
$38.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
29.85
52 Week Low
$0.33
$11.60
52 Week High
$5.75
$69.65

Technical Indicators

Market Signals
Indicator
CANG
TNXP
Relative Strength Index (RSI) 40.60 40.16
Support Level $0.33 $11.90
Resistance Level $0.50 $14.52
Average True Range (ATR) 0.06 0.76
MACD 0.01 -0.08
Stochastic Oscillator 11.24 12.50

Price Performance

Historical Comparison
CANG
TNXP

About CANG Cango Inc. each representing two (2)

Cango Inc is a Bitcoin mining company with a vision to establish an integrated, world-wide infrastructure platform capable of powering the future digital economy. The Company's mining operations span over 40 sites across North America, the Middle East, South America, and East Africa. Since entering the digital asset space in November 2024, Cango has activated pilot projects in both integrated energy solutions and distributed AI computing. In parallel, Cango continues to operate an online international used car export business through its subsidiary.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: